Amyotrophic Lateral Sclerosis (ALS)
What is Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects the nerve cells responsible for voluntary muscle movement. Most individuals with ALS retain their cognitive functions, meaning their thinking, memory, and decision-making abilities remain intact. However, some may experience cognitive or behavioral changes, which can be a source of concern for patients and caregivers. Understanding that cognition is often preserved can help alleviate fears about mental decline and focus on managing physical symptoms. These motor neurons—located in the brain, brainstem, and spinal cord—gradually deteriorate and die, leading to loss of communication between the nervous system and the muscles. As the condition advances, individuals experience increasing weakness, difficulty speaking, swallowing, and eventually breathing. ALS does not impact cognitive function in most individuals, but the progressive loss of motor control profoundly affects mobility, independence, and daily living. The disease can progress at different rates, but it is universally considered serious, life-altering, and medically complex.
What Are the Causes
The exact cause of ALS remains unknown, but research has identified several contributing factors. Genetic predisposition accounts for approximately 5–10% of cases, known as familial ALS, in which specific genetic mutations—such as SOD1, C9orf72, TARDBP, and FUS—are inherited. The remaining majority of cases are sporadic, meaning they occur without a clear family history. Environmental influences, including toxin exposure, occupational hazards, military service, viral infections, and traumatic injuries, have been studied as potential triggers, although no single factor has been proven to be definitive.
Despite continued scientific efforts, ALS remains one of the most challenging neurological disorders to understand fully, encouraging hope for future breakthroughs.
Symptoms
The exact cause of ALS remains unknown, but research has identified several contributing factors. Genetic predisposition accounts for approximately 5–10% of cases, known as familial ALS, in which specific genetic mutations—such as SOD1, C9orf72, TARDBP, and FUS—are inherited. The remaining majority of cases are sporadic, meaning they occur without a clear family history. Environmental influences, including toxin exposure, occupational hazards, military service, viral infections, and traumatic injuries, have been studied as potential triggers, although no single factor has been proven to be definitive.
Abnormal protein processing, oxidative stress, mitochondrial dysfunction, immune system dysregulation, and disruptions in neuronal communication have also been implicated. In many cases, ALS likely results from a combination of genetic susceptibility and external factors. Despite continued scientific efforts, the disease remains one of the most challenging neurological disorders to understand fully.
How Many People Are Affected
ALS is considered a rare disease, yet it affects a significant number of individuals worldwide. An estimated 300,000 people globally live with ALS at any given time, and approximately 5,000 new cases are diagnosed each year in the United States. The lifetime risk is about 1 in every 300 people, with the disease more commonly diagnosed between the ages of 40 and 70. Men are slightly more likely to develop ALS than women, although this gap narrows with age. Because ALS is progressive and currently incurable, prevalence remains relatively stable even as new cases are diagnosed annually.
Complications
As ALS advances, complications become increasingly significant and impact multiple aspects of daily life. Loss of mobility leads to difficulty walking, transferring, and performing basic tasks. Weakness of the respiratory muscles leads to shortness of breath, reduced oxygen levels, and an increased risk of respiratory infections. Many individuals eventually require non-invasive ventilation or other respiratory support. Swallowing difficulties can lead to malnutrition, dehydration, and aspiration pneumonia, which is a significant risk factor in ALS.
Communication becomes challenging as speech muscles weaken, often requiring the use of assistive communication devices. Muscle contractures, pain from immobility, pressure injuries, and increased risk of falls may also occur. Emotional challenges such as anxiety, depression, and frustration are common as individuals navigate life-changing physical limitations. The combination of physical progression and psychological weight underscores the importance of comprehensive support and proactive care.
Diagnosis
Diagnosing ALS involves a detailed neurological evaluation and the careful exclusion of conditions that may appear similar. Clinicians review symptom history, progression patterns, family background, and overall neurological function. A physical examination assesses muscle strength, reflexes, coordination, muscle tone, and the presence of fasciculations or atrophy.
Electromyography (EMG) and nerve conduction studies (NCS) are essential diagnostic tools that measure electrical activity in muscles and nerves, helping identify motor neuron deterioration. Imaging studies such as MRI may be used to rule out structural causes of symptoms. Laboratory tests help exclude metabolic disorders, autoimmune conditions, infections, and vitamin deficiencies. In rare situations, genetic testing may be performed to detect familial ALS mutations. Because ALS is a diagnosis of exclusion, a thorough and methodical approach is critical to ensure accuracy.
Treatment Options
While ALS currently has no cure, treatment focuses on slowing progression, managing symptoms, preserving function, and enhancing quality of life. FDA-approved medications—such as riluzole, edaravone, and AMX0035—may help slow functional decline in some patients. Respiratory support, including non-invasive ventilation, helps maintain breathing comfort and prolong survival. Speech therapy assists with communication, while occupational and physical therapy help maintain mobility, reduce stiffness, and optimize daily functioning.
In many instances, procedural interventions or regenerative options may help support function and repair, such as Exosomes, Stem Cells, and Peptides.
Nutritional support is crucial for maintaining weight and reducing the risk of complications from swallowing difficulties. Assistive devices such as walkers, wheelchairs, communication tools, and adaptive equipment improve safety and independence. Psychological counseling and palliative care provide emotional support and improve comfort as the disease progresses. A multidisciplinary approach involving neurologists, therapists, nutritionists, respiratory specialists, and social workers is considered the gold standard for long-term management.